DUCHEMBIO
Dyukem Bio Medical imaging scan (positron emission tomography, one person: PET) prescription drugs is a radiopharmaceutical used in a company to manufacture the meantime, nuclear medicine (Nuclear Medicine) income sales and co-operation of the relevant medical equipment, as well as radiopharmaceutical manufacturing By expanding the scope of supply and supply, we are now establishing a foundation as a comprehensive medical service company and will contribute to medical development.
DUCHEMBIO
Industry:
Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.duchembio.com
Status:
Active
Contact:
02-332-4868
Technology used in webpage:
SPF Nginx Google Apps For Business DigiCert SSL RapidSSL Korea Telecom Cafe24 DNS LINE WORKS
Current Employees Featured
Official Site Inspections
http://www.duchembio.com
- Host name: 183.111.199.231
- IP address: 183.111.199.231
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "DuChemBio"
๋์ผ๋ฐ์ด์ค
์ ์กฐ๊ธฐ์ ๊ธฐ๋ฐ์ ์ฐจ์ธ๋ ์ ์ง๋จ ๋ฐ ์น๋ฃ ๋ฐฉ์ฌ์ฑ์์ฝํ ๊ฐ๋ฐ ๊ธฐ์ (์ฃผ)๋์ผ๋ฐ์ด์คSee details»
DuChemBio | Company Profile - ๋์ผ๋ฐ์ด์ค
Greetings from DuChemBio CEO. The passion to challenge a new market where everything is a beginning! With our experience in Korea, we will pursue the passion in Southeast Asia. Go to Greetings from the CEO. Address 6,7F, 81, โฆSee details»
DuChemBio - Crunchbase Company Profile & Funding
Where is DuChemBio 's headquarters? DuChemBio is located in Seoul, Seoul-t'ukpyolsi, South Korea. Who invested in DuChemBio? DuChemBio is funded by Company K Partners. When โฆSee details»
Korea's No. 1 Radiopharmaceutical Company Innovation-driven ...
Duchembio, Co., Ltd. l Provider of next-generation diagnostic and therapeutic radiopharmaceuticals New Duchembio Overview 7 Company Name Duchembio Co., Ltd. CEO โฆSee details»
Duchembio Co., Ltd. - LinkedIn
Duchembio Co., Ltd. Pharmaceutical Manufacturing Seoul, NA 134 followers No. 1 Radiopharmaceutical company in Korea with cutting-edge technologySee details»
DuChemBio Co., Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DuChemBio Co., Ltd. of Daegu, Daegu. Get the latest business insights from Dun & Bradstreet.See details»
DuChemBio | Financial Information
Item: 2021: 2022: 2023: 1st Half of 2024: Amount Amount Amount Amount; Total assets: 59,986: 51,351: 49,277: 49,606: Total liabilities: 40,058: 33,757: 27,482: 25,356 ...See details»
DuChemBio - Products, Competitors, Financials, Employees, โฆ
According to the Korea Biotechnology Industry Organization (KoreaBIO), over 60 radiopharmaceuticals have received U.S. FDA approval, including 13 cancer treatments that โฆSee details»
DuChemBio - Contacts, Employees, Board Members, Advisors
Organization. DuChemBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. DuChemBio has โฆSee details»
DuChemBio Co., Ltd. - CMOCRO - Domain Name
The company is dedicated to the development, supply and commercialization of PET radio-pharmaceutical technology and tracers. DuChemBio develops and markets PET solutions that โฆSee details»
DuChemBio - Overview, News & Similar companies | ZoomInfo.com
Who is DuChemBio. Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET imaging tracers in South โฆSee details»
DuChemBio | Financial Information
DuChemBio has completed its own peculiar business scheme. It is expected to realize high profit from 2025. โป Launching schedules for new drugs. 68 Ga-PSMA-11. First half of 2023; FES. โฆSee details»
๊ธฐ์ ์๊ฐ - ๋์ผ๋ฐ์ด์ค
์ฐจ์ธ๋ ์ ์ง๋จ๊ณผ ์น๋ฃ์ฉ ๋ฐฉ์ฌ์ฑ์์ฝํ ์ ์ฝ๊ฐ๋ฐ ์ ๋ฌธ๊ธฐ์ ใ๋์ผ๋ฐ์ด์ค๋ ์ ์ง๋จ ๋ฐ ์น๋ฃ๋ฅผ ์ํ ๋ฐฉ์ฌ์ฑ์์ฝํ ์ ์ฝ ๊ฐ๋ฐ ์ ๋ฌธ๊ธฐ์ ์ผ๋ก์, ์ฐ์ ์ ๊ฐ์ฅ ํต์ฌ์์์ธ ์ ์กฐ๊ธฐ์ ๊ฐ๋ฐ์ ์ญ์ ์ ๋๊ณ โฆSee details»
DuChemBio | History - ๋์ผ๋ฐ์ด์ค
DuChemBio Co.,LTD.-DuChemBio Research Institute small-scale merger: 11. Launched FACBC (18F-Fluciclovine), 1st PET diagnostic agent for recurrent prostate cancer: 09. National โฆSee details»
ImaginAb and DuChemBio Announce Manufacturing and โฆ
Jun 16, 2022 About DuChemBio Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET โฆSee details»
Organization: Duchembio - Cbonds.com
Organization: Duchembio Organization name. Duchembio Co Ltd. Country name. Republic of Korea Country of registration- Industry. Miscellaneous Healthcare: Products and Services. โฆSee details»
DuChemBio Co. Ltd., advised by BGM, has signed an ... - BGM โฆ
News about our organization and our activities DuChemBio Co. Ltd., advised by BGM, has signed an Exclusive Development and Licensing Agreement with Yantai Dongcheng Pharmaceutical โฆSee details»
Duchembio files for IPO to grow radiopharma business
Nov 11, 2024 Radiopharmaceutical biotech and contract development and organization firm Duchembio Co. Ltd. filed a securities report to South Koreaโs Financial Services Commission โฆSee details»
DuChemBio | Greetings from CEO - ๋์ผ๋ฐ์ด์ค
DuChemBio. โCeaselessly Securing Manufacturing Technologiesโ The Radiopharmaceutical industry is clearly distinguished from other pharmaceutical businesses, particularly in terms of โฆSee details»